Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)

Go back to Goldman Sachs Reiterates Neutral Rating on Tarsus Pharmaceuticals (TARS)
(NASDAQ: TARS) Delayed: 69.20 +0.32 (0.46%)
Previous Close $68.88    52 Week High
Open $68.82    52 Week Low
Day High $69.70    P/E N/A 
Day Low $67.61    EPS
Volume 448,261